Moneycontrol PRO

business

Shantha Biotech's 5-in-1 vaccine up for WHO review

Shantha Biotech's Shan-5, its 5-in-1 vaccine, disqualified by the WHO on quality concerns, is now up for reassesment.

first published: Jun 19, 2013 05:48 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347